US Broker Ratings

Healthcare Services Group, Inc. (HCSG): Investor Outlook with 22.83% Potential Upside

Healthcare Services Group, Inc. (NASDAQ: HCSG), a stalwart in the healthcare sector, is drawing investor attention with its promising potential upside of 22.83%. With a market..

Kestra Medical Technologies (KMTS) Stock Analysis: Exploring a 73% Potential Upside

In the competitive healthcare sector, Kestra Medical Technologies, Ltd (KMTS) stands out with its innovative approach to cardiovascular disease management. Based in Kirkland, Washington, this company..

Pacira BioSciences, Inc. (PCRX): Investor Outlook with a Promising 34% Upside Potential

Pacira BioSciences, Inc. (NASDAQ: PCRX) is making waves in the healthcare sector, offering investors an intriguing prospect in the Drug Manufacturers – Specialty & Generic industry...

ImmunityBio, Inc. (IBRX) Stock Analysis: Exploring a Potential 373% Upside in the Biotech Arena

ImmunityBio, Inc. (NASDAQ: IBRX), a promising player in the burgeoning biotechnology industry, offers a unique investment opportunity with a staggering potential upside of 373%, according to..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Exploring the 130% Upside Potential

Beam Therapeutics Inc. (BEAM), a pioneering force in the biotechnology sector, is turning heads with its impressive potential upside of 130.47%. With a current market cap..

Opko Health, Inc. (OPK) Stock Analysis: A High-Risk Play with 214% Potential Upside

Opko Health, Inc. (NASDAQ: OPK), a prominent player in the healthcare sector, is attracting attention from individual investors due to its significant potential upside. With a..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Exploring a 45% Potential Upside with Strong Buy Ratings

Ocular Therapeutix, Inc. (OCUL) is capturing investor attention with its promising potential upside of 45.07% and unanimous buy recommendations from analysts. As a key player in..

Phreesia, Inc. (PHR) Stock Analysis: Strong Buy Ratings and Potential 18% Upside

Phreesia, Inc. (NASDAQ: PHR) is making waves in the healthcare sector with its innovative approach to health information services, offering a comprehensive SaaS-based software and payment..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: A 39% Potential Upside in the Biotech Arena

For investors seeking exposure in the healthcare sector, Scholar Rock Holding Corporation (NASDAQ: SRRK) presents a compelling opportunity with a robust potential upside of 39.23%. This..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Exploring a Potential 8.5% Upside Amid Robust CNS Innovation

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a notable player in the healthcare sector, is making waves in the biopharmaceutical landscape with its specialized focus on central nervous..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Exploring a 39% Potential Upside

Pediatrix Medical Group, Inc. (MD) stands as a notable entity within the healthcare sector, specifically in the medical care facilities industry. This U.S.-based company, with a..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: Exploring a 135% Potential Upside in the Biotech Sector

Investors eyeing the biotech sector might want to take a closer look at Amicus Therapeutics, Inc. (NASDAQ: FOLD), which stands out with a compelling potential upside..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Unveiling a Potential 31% Upside in the Medical Device Sector

Establishment Labs Holdings Inc (NASDAQ: ESTA), a Costa Rican-based medical technology company, is making waves in the healthcare sector, particularly within the medical devices industry. With..

MannKind Corporation (MNKD): Investor Outlook Shows 132% Potential Upside in Biotech Sector

MannKind Corporation (NASDAQ: MNKD) is making waves in the biotechnology sector with its promising potential for growth and innovation in therapeutic products for endocrine and orphan..

Dynavax Technologies Corporation (DVAX) Investor Outlook: Exploring a Potential 108.93% Upside

Dynavax Technologies Corporation (NASDAQ: DVAX), a prominent player in the healthcare sector, is drawing interest from investors with a substantial market cap of $1.34 billion. Specializing..

Twist Bioscience Corporation (TWST) Stock Analysis: Unveiling a 48% Potential Upside in Synthetic DNA Innovation

Twist Bioscience Corporation (NASDAQ: TWST), a prominent player in the healthcare sector’s diagnostics and research industry, has been making waves with its cutting-edge synthetic DNA-based products...

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: 66% Upside Potential Amidst Biotech Innovation

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a promising player in the biotechnology sector, is capturing the attention of investors with its robust R&D pipeline and potential for..

Novavax, Inc. (NVAX) Investor Outlook: Exploring Potential Upside Despite Volatile Valuation

Novavax, Inc. (NASDAQ: NVAX), a pioneering biotechnology company, is capturing the attention of investors with its ambitious vaccine development initiatives and a potential upside nearing 94.71%...

Veracyte, Inc. (VCYT) Stock Analysis: Exploring a 65.84% Potential Upside in the Healthcare Diagnostics Sector

Veracyte, Inc. (VCYT), a prominent player in the healthcare diagnostics sector, is capturing the attention of investors with a compelling potential upside of 65.84%, based on..

Immunocore Holdings plc (IMCR) Stock Analysis: Discovering the 91.97% Potential Upside in Biotechnology

Immunocore Holdings plc (NASDAQ: IMCR), a UK-based biotechnology company, is capturing investor interest with a promising potential upside of 91.97%, as indicated by its average target..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds